Gilead combo HIV pill matches Truvada efficacy but safer in trial
(Reuters) - Gilead Sciences Inc said on Wednesday its experimental fixed-dose combination treatment for HIV proved as effective in a late-stage study as the company's widely used Truvada combo pill but with significantly less loss of bone mineral density and kidney function. (Source: Reuters: Health)
Source: Reuters: Health - September 2, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
What Does a Post-HIV Gay Culture Look Like?
I have recently been confronting my personal issues with Truvada and in the process learning a lot about myself. But it got me wondering, what exactly will sex between men look like after HIV is effectively contained or eradicated? How will it affect gay male culture? And is that the goal of safe sex education and advocating for the use of PrEP? I believe a lot of gay media outlets are being disingenuous in the extreme by pretending as if PrEP and Truvada aren't about barebacking. The response, the #TruvadaWhore online campaign, was useless posturing because it didn't spark the conversation that needs to happen, which is...
Source: Healthy Living - The Huffington Post - August 26, 2015 Category: Consumer Health News Source Type: news
Daily H.I.V. Drug Regimen Is Effective in African Women, Study Says
A study found that 76 percent of young women in Cape Town, South Africa, who were assigned to take Truvada, a H.I.V.-prevention drug, were willing and able to take the pills daily. (Source: NYT Health)
Source: NYT Health - July 23, 2015 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Acquired Immune Deficiency Syndrome Cape Town (South Africa) Truvada (Drug) Tests (Medical) Source Type: news
FDA cracks down on 1,000 illegal online medicine sellers
(Reuters) — The FDA said yesterday it had sent warning letters and seized potentially dangerous, unapproved medicines and medical devices from more than 1,050 websites globally.
Inspectors from the FDA and other federal agencies screened and seized illegal drugs and medical devices received through international mail facilities in Chicago, Miami and New York, the FDA said in a statement.
The health regulator said it sent warning letters to operators of nearly 400 websites and to 9 firms distributing unapproved medical devices online.
The prescription drugs targeted included some purported to be the generic versions of ...
Source: Mass Device - June 19, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Business/Financial News Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news
PrEP is not linked to greater risk for depression
(Gladstone Institutes) A new paper out of the iPrEx study--a randomized, placebo-controlled trial of daily oral HIV pre-exposure prophylaxis (PrEP) in men and transgender women who have sex with men -- reported no link between taking Truvada for oral PrEP and experiencing depression. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2015 Category: Global & Universal Source Type: news
Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient - Lee M, Eyer F, Felgenhauer N, Klinker HH, Spinner CD.
A 21 year old MSM patient with newly diagnosed HIV infection was hospitalized in our department after ingestion of an overdose of his antiretroviral therapy (ART) comprising dolutegravir (DTG - Tivicay®) and tenofovir disaproxil fumarate/emtricitabine (T... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - June 13, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
ICYMI: Quantifying The Dad Bod And Why We Need More Black Doctors
ICYMI Health features what we're reading this week.
This week, we found ourselves drawn to stories about sexual politics in health. We were blown away by our colleagues Carina Kolodny and Amber Genuske's year-long project exploring the history and power of the clitoris. We also read up on an insurance company that said it would stop covering preventative HIV drugs to its peril, and about the retraction of a study that was published in the journal Science last year, claiming that gay canvassers were able to change voters' minds about gay marriage after only 22 minutes of conversation.
Read on and tell us in the comments...
Source: Healthy Living - The Huffington Post - May 23, 2015 Category: Consumer Health News Source Type: news
Gilead's low-dose, high-impact HIV drug heads to the FDA
A next-generation HIV drug from Gilead Sciences Inc., which could be more effective and have fewer side effects with a lower dosage, will go to federal regulators for a decision on whether it should be approved.
The drug — a combination of Gilead's emtricitabine and tenofovir alafenamide, or TAF — is the second so-called F/TAF drug submitted by the Foster City-based company to the Food and Drug Administration. In November, it filed for approval of a once-daily, single-tablet regimen containing… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 8, 2015 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Gilead's low-dose, high-impact HIV drug heads to the FDA
A next-generation HIV drug from Gilead Sciences Inc., which could be more effective and have fewer side effects with a lower dosage, will go to federal regulators for a decision on whether it should be approved.
The drug — a combination of Gilead's emtricitabine and tenofovir alafenamide, or TAF — is the second so-called F/TAF drug submitted by the Foster City-based company (NASDAQ: GILD) to the Food and Drug Administration. In November, it filed for approval of a once-daily, single-tablet regiment… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 7, 2015 Category: Biotechnology Authors: Ron Leuty Source Type: news
Gilead's low-dose, high-impact HIV drug heads to the FDA
A next-generation HIV drug from Gilead Sciences Inc., which could be more effective and have fewer side effects with a lower dosage, will go to federal regulators for a decision on whether it should be approved.
The drug — a combination of Gilead's emtricitabine and tenofovir alafenamide, or TAF — is the second so-called F/TAF drug submitted by the Foster City-based company (NASDAQ: GILD) to the Food and Drug Administration. In November, it filed for approval of a once-daily, single-tablet regiment… (Source: bizjournals.com Health Care:Hospitals headlines)
Source: bizjournals.com Health Care:Hospitals headlines - April 7, 2015 Category: Hospital Management Authors: Ron Leuty Source Type: news
HIV prevention finally has a game-changer, and it’s called Truvada
If the NHS and policymakers are bold, it could spell the end for HIV in the UK Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 26, 2015 Category: Science Authors: Michael Brady Tags: Aids and HIV Society Drugs Science NHS Health Source Type: news
Taking Pill Before, After Sex Cuts HIV Infection for Gay Men: Study
Research suggests that Truvada doesn't need to be taken daily, but more study still needed (Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - February 26, 2015 Category: Reproduction Medicine Authors: webmaster at doctorslounge.com Tags: Infections, AIDS, Pharmacy, Reproductive Medicine, News, Source Type: news
Pre-exposure Prophylaxis Halts Real-world HIV TransmissionPre-exposure Prophylaxis Halts Real-world HIV Transmission
Prophylactic treatment with tenofovir and emtricitabine is highly effective and likely has no effect on risk behavior, two new studies show. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 25, 2015 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news
Taking Pill Before, After Sex Cuts HIV Infection for Gay Men: Study
Research suggests that Truvada doesn't need to be taken daily, but more study still needed (Source: WebMD Health)
Source: WebMD Health - February 25, 2015 Category: Consumer Health News Source Type: news
Taking Pill Before, After Sex Cuts HIV Infection for Gay Men
Research suggests that Truvada doesn't need to be taken daily, but more study still neededSource: HealthDay
Related MedlinePlus Pages: Gay, Lesbian, Bisexual and Transgender Health, HIV/AIDS Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 25, 2015 Category: Consumer Health News Source Type: news
